PA
PNT

Perceptive Advisors’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Perceptive Advisors’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-800,000
Closed -$2.63M – 119
2023
Q3 		$2.63M Buy
800,000
+300,000
+60% +$2.49M 0.09% 79
2023
Q2 		$675K Buy
+500,000
New +$4.41M 0.02% 88

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Perceptive Advisors's PNT Position: Q1 2023 in Review

Perceptive Advisors sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q1 2023, closing a stake of 500,000 shares — an estimated $3.65M sold.

Perceptive Advisors first reported a position in PNT in Q3 2020 and held it in 10 quarters. The position peaked at $21.6M in Q3 2020. 115 funds tracked by Wall St. Rank hold PNT as of Q1 2023.

  • Perceptive Advisors reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Perceptive Advisors sold 500,000 POINT Biopharma Global Inc. Common Stock shares in Q1 2023, an estimated $3.65M.
  • Perceptive Advisors first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 10 quarters.
  • Perceptive Advisors's POINT Biopharma Global Inc. Common Stock position peaked at $21.6M in Q3 2020.
  • 115 funds tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q1 2023.

Based on Perceptive Advisors's 13F filing for Q1 2023, filed 15 May 2023.